Moomoo AI 已提取核心訊息
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have collectively filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on February 14, 2024, indicating a shared voting and dispositive power over 6,912,502 shares of bluebird bio, Inc. This represents 6.32% of the company's common stock. The filing, which is required due to the event date of December 31, 2023, signifies that the reporting persons have crossed the threshold of beneficial ownership that necessitates disclosure under the Securities Exchange Act of 1934. The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The principal business office for all reporting persons is located at 77 West Wacker Drive...Show More
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have collectively filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on February 14, 2024, indicating a shared voting and dispositive power over 6,912,502 shares of bluebird bio, Inc. This represents 6.32% of the company's common stock. The filing, which is required due to the event date of December 31, 2023, signifies that the reporting persons have crossed the threshold of beneficial ownership that necessitates disclosure under the Securities Exchange Act of 1934. The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The principal business office for all reporting persons is located at 77 West Wacker Drive, 7th Floor, Chicago, IL 60601. Alyeska Investment Group, L.P. and Alyeska Fund GP, LLC are organized in Delaware, while Anand Parekh is a citizen of the United States of America. The filing indicates that Alyeska Investment Group, L.P. is an investment adviser and a parent holding company or control person as per the SEC rules.
Alyeska Investment Group, L.P.、Alyeska Fund GP, LLC和Anand Parekh於2024年2月14日共同向美國證券交易委員會（SEC）提交了附表13G，表示對藍鳥生物公司的6,912,502股股票擁有共同投票權和處置權。這佔該公司普通股的6.32％。由於事件發生日期爲2023年12月31日，因此必須提交該文件，這表明申報人已經跨越了1934年《證券交易法》規定的受益所有權門檻，因此必須進行披露。這些股份是在正常業務過程中持有的，不是爲了改變或影響發行人的控制權。所有舉報人的主要業務辦公室位於伊利諾伊州芝加哥市西瓦克大道77號7樓60601。Al...展開全部
Alyeska Investment Group, L.P.、Alyeska Fund GP, LLC和Anand Parekh於2024年2月14日共同向美國證券交易委員會（SEC）提交了附表13G，表示對藍鳥生物公司的6,912,502股股票擁有共同投票權和處置權。這佔該公司普通股的6.32％。由於事件發生日期爲2023年12月31日，因此必須提交該文件，這表明申報人已經跨越了1934年《證券交易法》規定的受益所有權門檻，因此必須進行披露。這些股份是在正常業務過程中持有的，不是爲了改變或影響發行人的控制權。所有舉報人的主要業務辦公室位於伊利諾伊州芝加哥市西瓦克大道77號7樓60601。Alyeska Investment Group, L.P. 和 Alyeska Fund GP, LLC在特拉華州成立，而阿南德·帕雷克是美利堅合衆國公民。該文件顯示，根據美國證券交易委員會的規定，Alyeska Investment Group, L.P. 是一家投資顧問和母控股公司或控股人。
有用
沒用